BioNTech to shutter sites in Germany, Singapore as no buyers emerge — BioNTech announced on Monday that it will close manufacturing sites in Germany and Singapore after failing to find buyers, following its strategic pivot away from pandemic-era COVID-19 vaccine production. The company had (Reuters, 2026-09-28)
Rising Rates No Problem for US Stock Market's Shadiest Nook — Despite anticipated headwinds from rising bond yields, geopolitical tensions in Iran, and the Federal Reserve's inflation-fighting efforts, heavily shorted U.S. stocks are performing exceptionally well and approaching on (Bloomberg Business, 2026-09-25)
Moderna CEO's Realistic Approach to Innovation — Moderna's stock rose in August following positive developments in its therapeutic cancer vaccine targeting melanoma recurrence. At the Journal House event during the UN General Assembly, CEO Stéphane Bancel was questione (The Wall Street Journal, 2026-09-25)
Pharma deal fever boosts flurry of highly complex mergers — Pharmaceutical industry deal activity is surging as large drugmakers acquire smaller biotech rivals to address looming patent expiries, with 2026 already surpassing 2025's record of 35 deals valued at $1bn or more. The $ (Financial Times News, 2026-09-25)
Opinion | The Amazing Things AI Is Already Doing for Humanity — The article highlights the positive impacts of artificial intelligence across medicine, business, and employment, countering fears about job losses. It cites a Gallup survey on public concerns but emphasizes AI's life-sa (The Wall Street Journal, 2026-09-24)
BioNTech's mRNA Pioneers Name New Firm Arife, or 'the Wise One' — BioNTech cofounders Ugur Sahin and Özlem Türeci have named their new biotech venture Arife, meaning 'the wise one,' as they prepare to depart the company they helped build. The couple, who created the first commercial mR (Bloomberg Business, 2026-09-23)